Clerio Vision

Location: Rochester, New York

Main Description:

Clerio Vision is developing a novel vision correction procedure. Instead of changing the shape of the cornea, as current LASIK-based approaches do, its approach is to use a femtosecond laser to change the refractive index of the cornea with small pulses to “write” a corrective prescription onto the cornea non-invasively. Because this approach doesn’t thin the cornea, it can be repeated as needed to correct vision changes over a person’s lifetime.  The approach, called LIRIC, is being commercialized by some of the original architects of the world’s first LASIK systems.  Clerio’s core technology has been in development for over a decade and is based on over 40 issued and pending patents.  Currently over 150 million individuals in the U.S. alone require some form of vision correction.

Css Class: Clerio Vision

Category: Current SGEP Investments